Last reviewed · How we verify
NCT06281392
Artificial Intelligence and Dysplasia Detection in Inflammatory Bowel Disease (EIIDISIA Study)
NA trial testing CADe system in Inflammatory Bowel Diseases in 122 participants. Participants enrolled and being followed up; not accepting new ones.
20 June 2025
Quick facts
| Lead sponsor | Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | screening |
| Enrollment | 122 |
| Start date | 15 November 2023 |
| Primary completion | 20 June 2025 |
| Estimated completion | 20 November 2025 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- CADe system
- NBI
Conditions studied
- Inflammatory Bowel Diseases — all drugs for Inflammatory Bowel Diseases →
- Dysplasia — all drugs for Dysplasia →
Sponsor
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana — full company profile →
Who can join
18 and older, any sex, with Inflammatory Bowel Diseases or Dysplasia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Randomized clinical study analyzing the efficacy of colonoscopy assisted by the Computer Aided Detection (CADe) system compared to virtual chromoendoscopy with Narrow Band Imaging (NBI) in the detection of colon dysplasia in patients with long-standing inflammatory bowel disease (IBD).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06281392
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Inflammatory Bowel Diseases
Currently open trials in the same condition.
- NCT07520747 — A Database Study of Disease, Treatment Patterns and Healthcare Use in Children With Inflammatory Bowel Diseases in Korea · recruiting
- NCT07349472 — Pentoxifylline in Patients With Ulcerative Colitis · Phase 2 · recruiting
- NCT07033208 — Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance · NA · recruiting
- NCT06842316 — Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases · recruiting
- NCT06453317 — Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis · Phase 2 · recruiting
Other Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana trials
Trials by the same sponsor.
- NCT07391748 — Efficacy of a Polyhexanide Biguanide-Based Gel in the Prevention of Biofilm Formation in Pressure Ulcers · EARLY_PHASE1 · not yet recruiting
- NCT06888297 — RESCUE: European Certification for Second Victim Support · enrolling by invitation
- NCT07005544 — Hand Hygiene Skills Using Virtual Reality · NA · completed
- NCT06516276 — Technologies to Improve QoL of Prostate Cancer · NA · not yet recruiting
- NCT06512480 — Colorectal Surgery, a New Robotic Platform (Hugo Ras) · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06281392 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
- Last refreshed: 15 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06281392.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing